Skip to main content
main-content

02-02-2018 | Chronic myeloid leukemia | Editorial | Article

Discontinuing tyrosine kinase inhibitors in chronic myeloid leukemia

Author:
Ehab Atallah MD
Disclosures

Please log in to get access to this content

Related topics

image credits